1.Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation
Oh-Hyun LEE ; Young Dae KIM ; Jung-Sun KIM ; Nak-Hoon SON ; Hui-Nam PAK ; Boyoung JOUNG ; Cheol-Woong YU ; Hyun-Jong LEE ; Woong-Chol KANG ; Eun-Seok SHIN ; Rak-kyeong CHOI ; Do-Sun LIM ; Yo Han JUNG ; Hye-Yeon CHOI ; Kyung-Yul LEE ; Bang-Hoon CHO ; Sang Won HAN ; Joong Hyun PARK ; Han-Jin CHO ; Hyung Jong PARK ; Hyo Suk NAM ; Ji Hoe HEO ; Chak-yu SO ; Gary Shing-Him CHEUNG ; Yat-yin LAM ; Xavier FREIXA ; Apostolos TZIKAS ; Yangsoo JANG ; Jai-Wun PARK
Korean Circulation Journal 2021;51(7):626-638
Background and Objectives:
Prior studies have shown that stroke patients treated with percutaneous left atrial appendage occlusion (LAAO) for non-valvular atrial fibrillation (NVAF) experience better outcomes than similar patients treated with warfarin. We investigated the impact of percutaneous left atrial appendage closure on post-stroke neurological outcomes in NVAF patients, compared with non-vitamin K antagonist oral anticoagulant (NOAC) therapy.
Methods:
Medical records for 1,427 patients in multiple registries and for 1,792 consecutive patients at 6 Korean hospitals were reviewed with respect to LAAO or NOAC treatment.Stroke severity in patients who experienced ischemic stroke or transient ischemic attack after either treatment was assessed with modified Rankin Scale (mRS) scoring at hospital discharge and at 3 and 12 months post-stroke.
Results:
mRS scores were significantly lower in LAAO patients at 3 (p<0.01) and 12 months (p<0.01) post-stroke, despite no significant differences in scores before the ischemic cerebrovascular event (p=0.22). The occurrences of disabling ischemic stroke in the LAAO and NOAC groups were 36.7% and 44.2% at discharge (p=0.47), 23.3% and 44.2% at 3 months post-stroke (p=0.04), and 13.3% and 43.0% at 12 months post-stroke (p=0.01), respectively.Recovery rates for disabling ischemic stroke at discharge to 12 months post-stroke were significantly higher for LAAO patients (50.0%) than for NOAC patients (5.6%) (p<0.01).
Conclusions
Percutaneous LAAO was associated with more favorable neurological outcomes after ischemic cerebrovascular event than NOAC treatment.
2.Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation
Oh-Hyun LEE ; Young Dae KIM ; Jung-Sun KIM ; Nak-Hoon SON ; Hui-Nam PAK ; Boyoung JOUNG ; Cheol-Woong YU ; Hyun-Jong LEE ; Woong-Chol KANG ; Eun-Seok SHIN ; Rak-kyeong CHOI ; Do-Sun LIM ; Yo Han JUNG ; Hye-Yeon CHOI ; Kyung-Yul LEE ; Bang-Hoon CHO ; Sang Won HAN ; Joong Hyun PARK ; Han-Jin CHO ; Hyung Jong PARK ; Hyo Suk NAM ; Ji Hoe HEO ; Chak-yu SO ; Gary Shing-Him CHEUNG ; Yat-yin LAM ; Xavier FREIXA ; Apostolos TZIKAS ; Yangsoo JANG ; Jai-Wun PARK
Korean Circulation Journal 2021;51(7):626-638
Background and Objectives:
Prior studies have shown that stroke patients treated with percutaneous left atrial appendage occlusion (LAAO) for non-valvular atrial fibrillation (NVAF) experience better outcomes than similar patients treated with warfarin. We investigated the impact of percutaneous left atrial appendage closure on post-stroke neurological outcomes in NVAF patients, compared with non-vitamin K antagonist oral anticoagulant (NOAC) therapy.
Methods:
Medical records for 1,427 patients in multiple registries and for 1,792 consecutive patients at 6 Korean hospitals were reviewed with respect to LAAO or NOAC treatment.Stroke severity in patients who experienced ischemic stroke or transient ischemic attack after either treatment was assessed with modified Rankin Scale (mRS) scoring at hospital discharge and at 3 and 12 months post-stroke.
Results:
mRS scores were significantly lower in LAAO patients at 3 (p<0.01) and 12 months (p<0.01) post-stroke, despite no significant differences in scores before the ischemic cerebrovascular event (p=0.22). The occurrences of disabling ischemic stroke in the LAAO and NOAC groups were 36.7% and 44.2% at discharge (p=0.47), 23.3% and 44.2% at 3 months post-stroke (p=0.04), and 13.3% and 43.0% at 12 months post-stroke (p=0.01), respectively.Recovery rates for disabling ischemic stroke at discharge to 12 months post-stroke were significantly higher for LAAO patients (50.0%) than for NOAC patients (5.6%) (p<0.01).
Conclusions
Percutaneous LAAO was associated with more favorable neurological outcomes after ischemic cerebrovascular event than NOAC treatment.
3.Operative Treatment for Extensor Carpi Ulnaris Tendon Dislocation.
Bum Suk OH ; Yun Rak CHOI ; Il Hyun KO ; Won Taek OH ; Nam Gyu EOM ; Ho Jung KANG
The Journal of the Korean Orthopaedic Association 2018;53(3):256-263
PURPOSE: Extensor carpi ulnaris (ECU) subluxation has a low incidence rate, to date, there has only been a few studies evaluating the operative treatment for type of injury. The purpose of this study was to retrospectively analyze 11 patients with ECU subluxation who underwent operative treatment. MATERIALS AND METHODS: Between March 2005 and February 2015, 11 patients received operative treatment. Magnetic resonance imaging and dynamic ultrasound were used to make the diagnosis. ECU subluxation patterns were classified by the Inoue's classification system. There were two cases of type A, one case of type B, five cases of type C, and three cases unfit for Inoue's classification. We also found two cases of radial subluxation and one case of ulnar locked subluxation. In type A and B cases, ECU tendons were relocated then sheaths repair was performed, and the extensor retinaculum reconstruction was performed. In type C cases, the fibro-osseous sheaths were fixed. In the three unclassified cases, extensor retinaculum reconstruction was performed. In all cases, fibro-osseous sheaths were fixed using the anchor suture technique. We compared the clinical results based on the following: motion range of the wrist joint; grip strength; visual analogue scale (VAS) score; quick disabilities of the arm, shoulder and hand (Q-DASH) score; and Mayo wrist score. RESULTS: The median age of patients at the time of the operation was 32 years, and the average follow-up period was 11.2 months. There were five cases of triangular fibrocartilage complex tear, two cases of distal radioulnar joint instability, three cases of ECU split tear as accompanying injury. There were significant differences in the clinical results. The average motion range of the wrist increased compared with the preoperative value (84.7% to 92.4% compared to contralateral normal side). The postoperative VAS score, Q-DASH score and Mayo wrist score showed better results compared with the respective preoperative values (6.0 to 1.1, 40.9 to 12.4, 75.9 to 86.4). CONCLUSION: ECU subluxation is a rare occurrence. Dynamic ultrasound is useful in diagnosing ECU tendon subluxation. Satisfactory results can be obtained with the use of a proper technique, which depends on the type of subluxation.
Arm
;
Classification
;
Diagnosis
;
Dislocations*
;
Follow-Up Studies
;
Hand
;
Hand Strength
;
Humans
;
Incidence
;
Joint Instability
;
Magnetic Resonance Imaging
;
Retrospective Studies
;
Shoulder
;
Suture Techniques
;
Tears
;
Tendons*
;
Triangular Fibrocartilage
;
Ultrasonography
;
Wrist
;
Wrist Joint
4.Application of 3D Surface Scanners in Forensic Science and Medicine ( I ): Digital Storage of Human Skeletons and Development of Appraisal Methods for Incident Scenes.
Nak Eun CHUNG ; Hyung Nam KOO ; Hyun Moo KANG ; Sang Seob LEE ; Hye Jin PARK ; Hyung Joong KIM ; Kyung Rak LEE ; Ik Jo CHUNG ; Dae Yeol KIM ; Dal Won KIM ; Sang Beom LIM ; Saebomi LEE ; Han Soo HAN ; Jung LEE ; Jun Suk KIM ; Ki Woong MOON ; Byong Hyun KIM ; Kyun Woo CHO ; Jin Pyeo KIM ; Yeo Soo KIM ; Sung Ho KIM ; In Soo SEO ; Dae Kyun PARK ; Jae Kwang CHUNG ; Yi Suk KIM ; Seong Kyu CHOI ; U Young LEE ; Hoon LEE ; Chae Keun KIM ; In Soo LEE ; Hoon KANG ; Won Seob KIM ; Dong Kyu KIM ; Dong Soo KIM ; Hyeong Jin CHOI ; Dong Il PARK ; Hong Soon CHOI ; Si Ro KIM ; Yong Seok HEO
Korean Journal of Legal Medicine 2012;36(1):85-96
The aim of this project was to use 3D scanning data collected at incident scenes and various evidence to 1) develop surveying methods based on 3D data consisting of overall and detailed scene evidence, captured by long-range and micros-canner, which can be shared by personnel working in different fields such as forensic medicine, video analysis, physical analysis, traffic engineering, and fire investigation; 2) create digital storage for human skeletons and set the foundation for virtual anthropology; and 3) improve the credibility of 3D evidence by virtual remodeling and simulation of incident scenes and evidence to provide a basis for advanced and high-tech scientific investigation. Two complete skeletons of male and female were scanned using 3D micro-scanner. Each bone was successfully reproduced and assembled in virtual space. In addition, recreating evidence scheduled for invasive examination by creating RP (rapid prototype) was possible. These outcomes could play an important role in setting up the new field of virtual anthropology. Case-specific surveying methods were developed through analysis of 3D scanning data collected by long-range surface scanners at the scenes of vehicular accidents, falls, shootings, and violent crimes. A technique and recording method was also developed for detecting forged seals by micro-scanning the pressure exerted on the seal. Appraisal methods developed in this project could be utilized to secure 3D data of human skeletal remains and incident scenes, create a standard for application, and increase objectivity, reproducibility, and accuracy of scanning methods. We plan to develop case-specific 3D data analysis techniques to improve the credibility of analysis at the NFS and to establish a 3D data collection and analysis team.
Crime
;
Data Collection
;
Female
;
Fires
;
Forensic Medicine
;
Forensic Sciences
;
Humans
;
Male
;
Skeleton
;
Statistics as Topic
5.Metastatic Renal Cell Carcinoma in a Supraclavicular Lymph Node with No Known Primary: A Case Report.
Young Rak CHOI ; Hye Suk HAN ; Ok Jun LEE ; Sung Nam LIM ; Mi Jin KIM ; Myeong Ho YEON ; Hyun Jung JEON ; Ki Hyeong LEE ; Seung Taik KIM
Cancer Research and Treatment 2012;44(3):215-218
Although metastasis is relatively frequent in cases of renal cell carcinoma (RCC), metastasis in the cervical or supraclavicular lymph node (LN) is relatively rare. Moreover, cases of metastatic RCC with a non-identifiable kidney mass are extremely rare. Here, the authors report a case of metastatic RCC in a supraclavicular LN without a primary kidney lesion. A 69-year-old man presented with a progressively enlarging right supraclavicular mass. Incisional biopsy of the affected supraclavicular LN was performed, and histological examination revealed metastatic RCC. However, no tumor was found in either kidney, despite various examinations. The patient was treated with radiotherapy followed by sunitinib. After three months on sunitinib, a follow-up computed tomography scan revealed that the supraclavicular LN had markedly decreased, and after 20 months, the disease had not progressed. This case suggests that, even when there is no primary kidney lesion, clinicians must consider the possibility of metastatic RCC when evaluating patients with clear cell carcinoma with an unknown primary site.
Aged
;
Biopsy
;
Carcinoma, Renal Cell
;
Follow-Up Studies
;
Humans
;
Indoles
;
Kidney
;
Lymph Nodes
;
Neoplasm Metastasis
;
Pyrroles
6.A Case of Cardiac Amyloidosis With Diuretic-Refractory Pleural Effusions Treated With Bevacizumab.
Suk Hyang BAE ; Jin Yeon HWANG ; Woo Jae KIM ; Hyun Hwa YOON ; Jung Min KIM ; Young Hee NAM ; Hee Gyung BAEK ; Yong Rak CHO ; Sun Yi PARK ; Jeong Hwan KIM ; Sung Hyun KIM ; Tae Ho PARK ; Gi Nam LEE ; Seo Hee RHA ; Young Dae KIM
Korean Circulation Journal 2010;40(12):671-676
Cardiac amyloidosis describes a clinical disorder caused by infiltration of abnormal insoluble fibrils in the heart, characterized by progressive heart failure and a grave prognosis. Pleural effusion in cardiac amyloidosis may represent a sign of heart failure, but it can also result from pleural infiltration of amyloid, manifested by recurrent large fluid accumulations. Recently, the role of vascular endothelial growth factor (VEGF) has been implicated in the pathogenesis of refractory pleural effusion. We report a case of a 53 year-old female patient with cardiac amyloidosis who presented with recurrent accumulation of large pleural effusions. She was initially treated with high dose loop diuretics, but the pleural effusion persisted, with the daily amount of drainage averaging 1 L/day. Accumulation of pleural fluid did not subside after 3 cycles of melphalan/prednisolone therapy. After the introduction of bevacizumab, an anti-VEGF antibody, the amount of pleural effusion decreased significantly. Efficacy of anti-VEGF therapy for refractory pleural effusions needs to be defined through further studies.
Amyloid
;
Amyloidosis
;
Antibodies, Monoclonal, Humanized
;
Drainage
;
Female
;
Heart
;
Heart Diseases
;
Heart Failure
;
Humans
;
Pleural Effusion
;
Prognosis
;
Sodium Potassium Chloride Symporter Inhibitors
;
Vascular Endothelial Growth Factor A
;
Bevacizumab
7.Polymorphism of a COLIA1 Gene Sp1 Binding Site in Korean Women with Pelvic Organ Prolapse.
Hye Jin CHO ; Hyun Joo JUNG ; Sei Kwang KIM ; Jong Rak CHOI ; Nam Hoon CHO ; Sang Wook BAI
Yonsei Medical Journal 2009;50(4):564-568
PURPOSE: To evaluate the possible influence of G-->T substitution at the Sp1-binding site of the COLIA1 gene on the risk of pelvic organ prolapse (POP). MATERIALS AND METHODS: The study group consisted of 15 women with advanced stage POP. Fifteen control subjects with uterine myomas among the postmenopausal women were matched for age and parity. DNA was obtained from peripheral blood leukocytes. The fragments of the first intron of the COLIA1 gene were amplified by real time polymerase chain reaction. The polymorphism was identified using LightCycler Technology with hybridization probes. Sequencing reactions were performed on each template using commercial primer. RESULTS: Two groups had no significant difference in medical history, surgical, and smoking history. The homozygous peaks in two groups were noted at 57degrees C on melting curve analysis. Sequencing reactions confirmed the G/G alleles in the 30 specimens tested. We could not find any polymorphism at the Sp1-binding site in COLIA1 gene with advanced stage POP. Statistical significance was considered to be p < .05. CONCLUSION: The polymorphism of the Sp1-binding site in the COLIA1 gene did not contribute to the development of POP in Korea.
Aged
;
Asian Continental Ancestry Group/genetics
;
Binding Sites/genetics
;
Collagen Type I/*genetics
;
Female
;
Genetic Predisposition to Disease
;
Humans
;
Middle Aged
;
Pelvic Organ Prolapse/*genetics
;
Polymerase Chain Reaction
;
Polymorphism, Genetic/*genetics
;
Sp1 Transcription Factor/*metabolism
8.A Case Report on the Inflation Failure of Distal Portion of Inoue Balloon during Percutaneous Mitral Valvuloplasty in a Patient with Rheumatic Mitral Stenosis.
Jang Ha KIM ; Sung Hoon JUNG ; Nam Hoon KIM ; Ji Heon JUNG ; Joung Eun SOH ; Seung Joon LEE ; Young Hee KIM ; Byung Ho LEE ; Joo Young HAN ; Rak Kyeong CHOI ; Dal Soo LIM ; Seok Geun HONG ; Hweung Kon HWANG
Korean Circulation Journal 2002;32(10):906-910
Since Inoue et al introduced a specially designed balloon catheter for percutaneous mitral valvuloplasty (PMV) in 1984, the Inoue balloon catheter has been a popular device for the management of mitral stenosis. During the procedure several fatal complications, such as cardiac tamponade, perforation of a cardiac chamber, atrial septal defect, thromboembolism, mitral regurgitation and death have all been reported in the literature. There have also been several international reports regarding deformities of the Inoue balloon, but few reports in Korea. We recently experienced a case of an inflation failure of the distal portion of the Inoue balloon during a percutaneous mitral valvuloplasty in a 34 year old female patient with a tight mitral stenosis. To the best of our knowledge, a similar deformity of an Inoue balloon has never been reported in Korea.
Adult
;
Cardiac Tamponade
;
Catheters
;
Congenital Abnormalities
;
Female
;
Heart Septal Defects, Atrial
;
Humans
;
Inflation, Economic*
;
Korea
;
Mitral Valve Insufficiency
;
Mitral Valve Stenosis*
;
Thromboembolism
9.A Case of Mitral Regurgitation due to Isolated Cleft Mitral Valve.
Tae Hee LEE ; Hye Sook CHOI ; Eun Sun JIN ; Jang Ha KIM ; Joo Young HAN ; Nam Heun KIM ; Young Hee KIM ; Seung Mook JUNG ; Rak Kyung CHOI ; Dal Soo LIM ; Suk Keun HONG ; Hweung Kon HWANG
Korean Circulation Journal 2002;32(10):902-905
A cleft in the anterior mitral valve leaflet is commonly associated with an atrioventricular septal defect, but an isolated cleft mitral valve is a rare condition. We report a case of a 27-year-old woman with severe mitral regurgitation due to an isolated cleft mitral valve. The echocardiography showed an anterior cleft on the mitral valve, but a normal sized and positioned left ventricular papillary muscle without septal defect. Under the diagnosis of mitral regurgitation due to the isolated cleft mitral valve the patient underwent mitral cleft repair. After surgery, the further echocardiography showed no mitral regurgitation.
Adult
;
Diagnosis
;
Echocardiography
;
Female
;
Humans
;
Mitral Valve Insufficiency*
;
Mitral Valve*
;
Papillary Muscles
10.Fractionated Stereotactic Radiation Therapy for Intracranial Benign Tumor: Preliminary Results of Clinical Application.
Dae Yong KIM ; Yong Chan AHN ; Seung Jae HUH ; Dong Rak CHOI ; Jong Hyun KIM ; Jung Il LEE ; Kwan PARK ; Do Hyun NAM ; Moon Kyung KIM
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1998;16(2):185-194
PURPOSE: With the development of stereotactic immobilization systems capable of reliable serial repositioning, fractionated stereotactic radiation therapy (FSRT) offers the potential for an improved treatment outcome by excellent dose delivery, and dose distribution characteristics with the favorable radiobiological properties of fractionated irradiation. We describe our initial experience using FSRT for the treatment of intracranial benign tumor. MATERIALS AND METHODS: Between August 1995 and December 1996, 15 patients (7 males and 8 females aged 6-70 years) were treated with FSRT. The patients had the following diagnosis : pituitary adenoma (10) including one patient who previously had received radiotherapy, craniopharyngioma (2), acoustic neurinoma (1), meningioma (2). Using the Gill-Thomas-Cosman relocatable head frame and multiple non-coplanar therapy, the daily dose of 2Gy was irradiated at 90% to 100% isodose surface of the isocenter. The collimator sizes ranged from 26mm to 70mm. RESULTS: In all patients except one follow-up lost, disease was well- controlled. Acute complication was negligible and no patient experienced cranial nerve neuropathies and radiation necrosis. In overall patient setup with scalp measurements, reproducibility was found to have mean of 1.1+/-0.6mm from the baseline reading. CONCLUSION: Relocatable stereotactic system for FSRT is highly reproducible and comfortable. Although the follow-up period was relatively short, FSRT is considered to be a safe and effective radiation technique as the treatment of intracranial tumor. But the fractionation schedule (fraction size, overall treatment time and total dose) still remains to be solved by further clinical trials.
Adenoma
;
Appointments and Schedules
;
Cranial Nerves
;
Craniopharyngioma
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Head
;
Humans
;
Immobilization
;
Male
;
Meningioma
;
Necrosis
;
Neuroma, Acoustic
;
Pituitary Neoplasms
;
Radiotherapy
;
Scalp
;
Treatment Outcome

Result Analysis
Print
Save
E-mail